Related Experiment Video
Updated: Mar 13, 2026

08:48
Author Spotlight: Decoding Mitochondrial Aging
Published on: June 30, 2023
5.0K
Mitochondrial Aspects of Synaptic Dysfunction in Alzheimer's Disease
Journal of Alzheimer'S Disease : JAD
|October 22, 2016
Summary
Alzheimer
Area of Science:
- Neuroscience
- Cell Biology
- Biochemistry
Background:
- Alzheimer's disease (AD) involves amyloid plaques, tau tangles, and cognitive decline.
- Synaptic damage is an early AD hallmark, strongly correlating with memory loss.
- Mitochondria are crucial for synaptic function, energy supply, and calcium buffering.
Purpose of the Study:
- To review molecular mechanisms of mitochondrial function at synapses.
- To highlight disturbances in mitochondrial dynamics and transport in Alzheimer's disease.
- To discuss the impact of these alterations on synaptic vesicle release and AD pathology.
Main Methods:
- Review of existing literature on mitochondrial function in neurons.
- Analysis of studies investigating amyloid-beta and tau effects on mitochondria.
- Examination of research on mitochondrial transport and dynamics in Alzheimer's disease models.
Main Results:
- Mitochondrial abnormalities are early and prominent features in Alzheimer's disease brains.
- Both amyloid-beta and tau initiate mitochondrial alterations.
- Mitochondrial dysfunction is implicated in synaptic failure and neuronal degeneration in AD.
Conclusions:
- Mitochondrial perturbation is a key factor in synaptic failure and degeneration in Alzheimer's disease.
- Dysfunctional mitochondria contribute significantly to synaptic pathology in AD.
- Targeting mitochondria represents a promising therapeutic strategy for Alzheimer's disease.
Keywords:
ATP supplyAlzheimer’s diseaseamyloid-βaxonal transportmitochondrial traffickingneurotransmitteroxidative stresssynaptic pathologysynaptic vesicle releasetauMore Related Videos
06:07Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
Published on: June 23, 2023
2.4K
06:41Quantitative Analysis of Mitochondria-Associated Endoplasmic Reticulum Membrane (MAM) Stabilization in a Neural Model of Alzheimer's Disease (AD)
Published on: January 10, 2025
1.3K
Related Concept Videos
Alzheimer's Disease: Overview
1.9K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.9K
Role of Neurotransmitters in Memory
2.8K
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
2.8K
Long-term Depression
3.5K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
3.5K
Long-term Depression
33.6K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
33.6K
Alzheimer's Disease: Treatment
1.1K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.1K
Mitochondria
21.1K
Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
21.1K